Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6532498
[patent_doc_number] => 20100221346
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Method For Transfecting Cells Using A Magnetic Field'
[patent_app_type] => utility
[patent_app_number] => 12/690731
[patent_app_country] => US
[patent_app_date] => 2010-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 29120
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221346.pdf
[firstpage_image] =>[orig_patent_app_number] => 12690731
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/690731 | Method For Transfecting Cells Using A Magnetic Field | Jan 19, 2010 | Abandoned |
Array
(
[id] => 6440631
[patent_doc_number] => 20100104507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'USE OF STERICALLY STABILIZED CATIONIC LIPOSOMES TO EFFICIENTLY DELIVER CPG OLIGONUCLEOTIDES IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 12/647320
[patent_app_country] => US
[patent_app_date] => 2009-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 22160
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104507.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647320
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647320 | USE OF STERICALLY STABILIZED CATIONIC LIPOSOMES TO EFFICIENTLY DELIVER CPG OLIGONUCLEOTIDES IN VIVO | Dec 23, 2009 | Abandoned |
Array
(
[id] => 9482856
[patent_doc_number] => 08728806
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-05-20
[patent_title] => 'Methods and compositions related to Th-1 dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 13/132517
[patent_app_country] => US
[patent_app_date] => 2009-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 17
[patent_no_of_words] => 30128
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13132517
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/132517 | Methods and compositions related to Th-1 dendritic cells | Dec 3, 2009 | Issued |
Array
(
[id] => 6426683
[patent_doc_number] => 20100151573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'Compositions and methods for delivery of molecules to selectin-ligand-expressing and selectin-expressing cells'
[patent_app_type] => utility
[patent_app_number] => 12/590965
[patent_app_country] => US
[patent_app_date] => 2009-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 11683
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151573.pdf
[firstpage_image] =>[orig_patent_app_number] => 12590965
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/590965 | Compositions and methods for delivery of molecules to selectin-ligand-expressing and selectin-expressing cells | Nov 16, 2009 | Abandoned |
Array
(
[id] => 6441124
[patent_doc_number] => 20100104544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'SELECTIVE CELL THERAPY FOR THE TREATMENT OF RENAL FAILURE'
[patent_app_type] => utility
[patent_app_number] => 12/618179
[patent_app_country] => US
[patent_app_date] => 2009-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 11889
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104544.pdf
[firstpage_image] =>[orig_patent_app_number] => 12618179
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/618179 | Selective cell therapy for the treatment of renal failure | Nov 12, 2009 | Issued |
Array
(
[id] => 6280033
[patent_doc_number] => 20100119454
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Use of the conserved Drosophila NPFR1 system for uncovering interacting genes and pathways important in nociception and stress response'
[patent_app_type] => utility
[patent_app_number] => 12/590159
[patent_app_country] => US
[patent_app_date] => 2009-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 26947
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119454.pdf
[firstpage_image] =>[orig_patent_app_number] => 12590159
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/590159 | Use of the conserved Drosophila NPFR1 system for uncovering interacting genes and pathways important in nociception and stress response | Nov 2, 2009 | Abandoned |
Array
(
[id] => 6063331
[patent_doc_number] => 20110201120
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'METHOD FOR INTRODUCING GENE INTO CELL, AND COMPOSITION FOR USE IN THE METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/124434
[patent_app_country] => US
[patent_app_date] => 2009-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5770
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201120.pdf
[firstpage_image] =>[orig_patent_app_number] => 13124434
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124434 | Method for introducing gene into cell, and composition for use in the method | Oct 12, 2009 | Issued |
Array
(
[id] => 6014818
[patent_doc_number] => 20110223153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-15
[patent_title] => 'MODIFIED SILK FILMS CONTAINING GLYCEROL'
[patent_app_type] => utility
[patent_app_number] => 13/122837
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 10766
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20110223153.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122837
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122837 | MODIFIED SILK FILMS CONTAINING GLYCEROL | Oct 8, 2009 | Abandoned |
Array
(
[id] => 10103781
[patent_doc_number] => 09139554
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Amino lipids and methods for the delivery of nucleic acids'
[patent_app_type] => utility
[patent_app_number] => 13/123307
[patent_app_country] => US
[patent_app_date] => 2009-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 40679
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13123307
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/123307 | Amino lipids and methods for the delivery of nucleic acids | Oct 8, 2009 | Issued |
Array
(
[id] => 11261693
[patent_doc_number] => 09485972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-08
[patent_title] => 'Truncated tau proteins'
[patent_app_type] => utility
[patent_app_number] => 12/574414
[patent_app_country] => US
[patent_app_date] => 2009-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 32
[patent_no_of_words] => 24554
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12574414
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/574414 | Truncated tau proteins | Oct 5, 2009 | Issued |
Array
(
[id] => 6271118
[patent_doc_number] => 20100255041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'REMEDY FOR THE TREATMENT OF CARDIO-VASCULAR DISEASES OR DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/573281
[patent_app_country] => US
[patent_app_date] => 2009-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 16105
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20100255041.pdf
[firstpage_image] =>[orig_patent_app_number] => 12573281
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/573281 | Remedy for the treatment of cardio-vascular diseases or disorders | Oct 4, 2009 | Issued |
Array
(
[id] => 6378671
[patent_doc_number] => 20100081711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'Cytotoxic agents'
[patent_app_type] => utility
[patent_app_number] => 12/585985
[patent_app_country] => US
[patent_app_date] => 2009-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9806
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081711.pdf
[firstpage_image] =>[orig_patent_app_number] => 12585985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/585985 | Cytotoxic agents | Sep 29, 2009 | Abandoned |
Array
(
[id] => 6442254
[patent_doc_number] => 20100104629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'CATIONIC LIPIDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/557294
[patent_app_country] => US
[patent_app_date] => 2009-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 44783
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104629.pdf
[firstpage_image] =>[orig_patent_app_number] => 12557294
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/557294 | CATIONIC LIPIDS AND USES THEREOF | Sep 9, 2009 | Abandoned |
Array
(
[id] => 6280895
[patent_doc_number] => 20100119610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'PACKAGED PEGYLATED GOLD NANOPARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/545139
[patent_app_country] => US
[patent_app_date] => 2009-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1616
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20100119610.pdf
[firstpage_image] =>[orig_patent_app_number] => 12545139
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/545139 | PACKAGED PEGYLATED GOLD NANOPARTICLES | Aug 20, 2009 | Abandoned |
Array
(
[id] => 10863933
[patent_doc_number] => 08889631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-11-18
[patent_title] => 'Disruptors of early/recycling endosomes'
[patent_app_type] => utility
[patent_app_number] => 12/543313
[patent_app_country] => US
[patent_app_date] => 2009-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 31
[patent_no_of_words] => 15424
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12543313
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/543313 | Disruptors of early/recycling endosomes | Aug 17, 2009 | Issued |
Array
(
[id] => 6479017
[patent_doc_number] => 20100285128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'SPACE FILLED DRUG RELEASE STRUCTURE AND METHOD OF MANUFACTURING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 12/539271
[patent_app_country] => US
[patent_app_date] => 2009-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5859
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20100285128.pdf
[firstpage_image] =>[orig_patent_app_number] => 12539271
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/539271 | SPACE FILLED DRUG RELEASE STRUCTURE AND METHOD OF MANUFACTURING THE SAME | Aug 10, 2009 | Abandoned |
Array
(
[id] => 5952624
[patent_doc_number] => 20110033542
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-10
[patent_title] => 'SUBLINGUAL AND BUCCAL FILM COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/537580
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15509
[patent_no_of_claims] => 65
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20110033542.pdf
[firstpage_image] =>[orig_patent_app_number] => 12537580
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/537580 | SUBLINGUAL AND BUCCAL FILM COMPOSITIONS | Aug 6, 2009 | Abandoned |
Array
(
[id] => 8896311
[patent_doc_number] => 08475832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-02
[patent_title] => 'Sublingual and buccal film compositions'
[patent_app_type] => utility
[patent_app_number] => 12/537571
[patent_app_country] => US
[patent_app_date] => 2009-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11949
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12537571
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/537571 | Sublingual and buccal film compositions | Aug 6, 2009 | Issued |
Array
(
[id] => 5558197
[patent_doc_number] => 20090269774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'EVALUATION OF EOSINOPHILIC ESOPHAGITIS'
[patent_app_type] => utility
[patent_app_number] => 12/492456
[patent_app_country] => US
[patent_app_date] => 2009-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 25386
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269774.pdf
[firstpage_image] =>[orig_patent_app_number] => 12492456
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/492456 | EVALUATION OF EOSINOPHILIC ESOPHAGITIS | Jun 25, 2009 | Abandoned |
Array
(
[id] => 5485880
[patent_doc_number] => 20090275645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'METHOD TO INDUCE NEOVASCULAR FORMATION AND TISSUE REGENERATION'
[patent_app_type] => utility
[patent_app_number] => 12/487398
[patent_app_country] => US
[patent_app_date] => 2009-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14142
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275645.pdf
[firstpage_image] =>[orig_patent_app_number] => 12487398
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/487398 | METHOD TO INDUCE NEOVASCULAR FORMATION AND TISSUE REGENERATION | Jun 17, 2009 | Abandoned |